{"transactions":[{"id":2080985,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-19T18:53:26.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":9578,"price":0.41,"value":3926.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":32412,"source":{"system":"sec-edgar","filing":"0001593968-22-001746","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001746/primary_01.xml","form_type":"4"}},{"id":2137472,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"grant","acquired":true,"shares":1760,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":1760,"derivative":{"exercise_price":2.16,"exercise_date":"2021-02-01","expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":1760},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137471,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"grant","acquired":true,"shares":24587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":24587,"derivative":{"exercise_price":2.16,"exercise_date":"2021-02-01","expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":24587},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137470,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"grant","acquired":true,"shares":10427,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":10427,"derivative":{"exercise_price":2.16,"exercise_date":"2022-08-12","expiration_date":"2031-08-12","underlying":"Common Stock","underlying_shares":10427},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137469,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"grant","acquired":true,"shares":26220,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":26220,"derivative":{"exercise_price":2.16,"exercise_date":"2022-08-12","expiration_date":"2031-08-12","underlying":"Common Stock","underlying_shares":26220},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137468,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"disposition_to_issuer","acquired":false,"shares":1760,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.77,"exercise_date":"2021-02-01","expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":1760},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137467,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"disposition_to_issuer","acquired":false,"shares":26220,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":10.25,"exercise_date":"2022-08-12","expiration_date":"2031-08-12","underlying":"Common Stock","underlying_shares":26220},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137466,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"disposition_to_issuer","acquired":false,"shares":10427,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":0,"derivative":{"exercise_price":10.25,"exercise_date":"2022-08-12","expiration_date":"2031-08-12","underlying":"Common Stock","underlying_shares":10427},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2137465,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option (right to buy)","published_at":"2022-10-13T06:02:59.000Z","date":"2022-10-10","kind":"disposition_to_issuer","acquired":false,"shares":24587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.77,"exercise_date":"2021-02-01","expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":24587},"source":{"system":"sec-edgar","filing":"0001593968-22-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822001522/primary_01.xml","form_type":"4"}},{"id":2352294,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option Grant (right to buy)","published_at":"2022-03-03T20:54:54.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":125000,"price":3.11,"value":388750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2022, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":125000,"derivative":{"exercise_price":3.11,"exercise_date":"2022-02-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001593968-22-000636","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000159396822000636/primary_01.xml","form_type":"4"}},{"id":2601793,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-16T20:07:01.000Z","date":"2021-08-12","kind":"grant","acquired":true,"shares":36647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the Stock Option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years."}],"balance_after":36647,"derivative":{"exercise_price":10.25,"expiration_date":"2031-08-11","underlying":"Common Stock","underlying_shares":36647},"source":{"system":"sec-edgar","filing":"0001209191-21-051723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1771994/000120919121051723/doc4.xml","form_type":"4"}},{"id":3550965,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-23T19:14:05.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":20935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022."}],"balance_after":20935,"derivative":{"exercise_price":6.36,"expiration_date":"2029-03-03","underlying":"Common Stock","underlying_shares":20935},"source":{"system":"sec-edgar","filing":"0001209191-19-025631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025631/doc4.xml","form_type":"4"}},{"id":3550964,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-23T19:14:05.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on April 2, 2021."}],"balance_after":24000,"derivative":{"exercise_price":5.96,"expiration_date":"2028-04-01","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-19-025631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025631/doc4.xml","form_type":"4"}},{"id":3550963,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-23T19:14:05.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":8083,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14083,"source":{"system":"sec-edgar","filing":"0001209191-19-025631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025631/doc4.xml","form_type":"4"}},{"id":3550962,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-23T19:14:05.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-025631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025631/doc4.xml","form_type":"4"}},{"id":3552024,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-19T21:30:08.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":20935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022."}],"balance_after":20935,"derivative":{"exercise_price":6.36,"expiration_date":"2029-03-03","underlying":"Common Stock","underlying_shares":20935},"source":{"system":"sec-edgar","filing":"0001209191-19-025408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025408/doc4.xml","form_type":"4"}},{"id":3552023,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-19T21:30:08.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will be fully vested and exercisable on April 2, 2021."}],"balance_after":24000,"derivative":{"exercise_price":5.96,"expiration_date":"2028-04-01","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-19-025408","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025408/doc4.xml","form_type":"4"}},{"id":3552022,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-19T21:30:08.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":8083,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14083,"source":{"system":"sec-edgar","filing":"0001209191-19-025408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025408/doc4.xml","form_type":"4"}},{"id":3552021,"issuer":{"id":156931,"kind":"organization","name":"Insys Therapeutics, Inc.","symbol":"INSY"},"owners":[{"id":121454,"kind":"person","name":"Vanhove Geertrui","position":1,"cik":"0001771994","reported_name":"Vanhove Geertrui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-19T21:30:08.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-19-025408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516479/000120919119025408/doc4.xml","form_type":"4"}}]}